Incisive Consultants Support the Fight Against ALS
After a company-wide campaign to collect funds and increase awareness for Amyotrophic Lateral Sclerosis (ALS) raised almost $15,000, Incisive was invited to visit the Johns Hopkins Department of Neurology research facility in November 2022 by the Fund for Johns Hopkins Medicine. Incisive was moved to support ALS and the #weaksidestrong challenge after Incisive’s Chief Revenue Officer, Corey Kosch, lost his father to ALS in 2022. The team wanted to contribute to the important work being done at Johns Hopkins to aid in finding a cure for a disease that devastates millions worldwide.
The Incisive Consultants team had the opportunity to visit the Johns Hopkins Department of Neurology and meet with Dr. Nicholas Maragakis, Associate Professor in the Johns Hopkins Department of Neurology and Co-Director of the ALS Clinic to learn more about their stem cell research and tour the laboratories where PhD students, post-doctorate fellows, and medical doctors conduct groundbreaking work in this field. Dr. Maragakis and his team are focused on the role of astrocytes in neurodegenerative diseases, specifically ALS.
Gina Scalise, Senior Associate Director of Development for the Fund for Johns Hopkins Medicine, worked closely with Incisive Consultants to coordinate an informative and meaningful visit. Incisive was represented by CEO, Chris Blackerby, CRO, Corey Kosch, Director of Operations, Jessica Wu, and VP of Talent, Cara Hodgson. While onsite, Dr. Maragakis and his team shared their latest research findings and showed the Incisive team around the laboratories where they conduct stem cell research.
“When my dad was diagnosed with ALS, it was hard not to feel a sense of hopelessness,” said Kosch. “After seeing the incredible research and development of new therapies to treat and potentially reverse the damage of ALS at Johns Hopkins, I am incredibly hopeful for a future where an ALS diagnosis does not equal a death sentence."
Incisive hopes to continue supporting the Fund for Johns Hopkins Medicine in the future and looks forward to seeing the progress being made in the fight against ALS.